MarkBernardZimeringMD

Endocrinology • Lakewood, NJ

Diabetes, Lipid Metabolism

Associate Professor, Medicine, UMDNJ-Robert Wood Johnson Medical School

Join to view full profile

Dr. Zimering is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zimering's full profile

Already have an account?

Office
1771 Madison Ave
Lakewood, NJ 08701
Phone+1 732-364-2144

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
Clinical Center at the National Institutes of HealthResidency, Internal Medicine, 1986 - 1987
Hennepin HealthcareResidency, Internal Medicine, 1984 - 1986
Albert Einstein College of MedicineClass of 1984

Certifications & Licensure

NJ State Medical License 1991 - 2025
MD State Medical License 1986 - 1991
MN State Medical License 1985 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

175 citations
Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia
Erik A. Imel, Munro Peacock, Pisit Pitukcheewanont, Howard J. Heller, Leanne M Ward
The Journal of Clinical Endocrinology and Metabolism. 2006-06-01
18 citations
Anti-endothelial and anti-neuronal effects from auto-antibodies in subsets of adult diabetes having a cluster of microvascular complications.
Mark B Zimering, Janet Alder, Zui Pan, Robert J. Donnelly
Diabetes Research and Clinical Practice. 2011-07-01
31 citations
Autoantibodies in type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells.
Mark B Zimering, Zui Pan
The Journal of Clinical Endocrinology and Metabolism. 2009-05-01